LINDA AGYEIWAA: Open Payments
NPI 1568215960 · WILLINGBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 22 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $375 |
| Teva Pharmaceuticals USA, Inc. | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
Products named: ARISTADA, LYBALVI, AUSTEDO XR, ABILIFY ASIMTUFII, INVEGA, UZEDY, VIVITROL.
Industry payments across NJ — which companies pay providers there.
